COMMUNIQUÉS West-GlobeNewswire

DBV Technologies Provides Update on Regulatory Progress for Viaskin Peanut
14/02/2018
Press Release Montrouge, France, February 14, 2018 DBV Technologies Provides Update on Regulatory Progress for Viaskin Peanut DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today [...]
DBV Technologies annonce les avancées réglementaires de Viaskin Peanut
14/02/2018
Communiqué de presse Montrouge, France, le 14 février 2018 (7h30 CET) DBV Technologies annonce les avancées réglementaires de Viaskin Peanut DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: [...]
Novartis forms alliance to develop medicines for treating infectious diarrheal disease
14/02/2018
Novartis receives funding from Bill & Melinda Gates Foundation for further development of Novartis drug candidate KDU731 for the treatment of cryptosporidiosis Cryptosporidiosis is the second leading cause of [...]
Sensorion Presents New SENS-401 Data at ARO 2018 MidWinter Meeting
14/02/2018
MONTPELLIER, France, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468:ALSEN), a biotech company specializing in the treatment of inner ear diseases, today announces new data presented in multiple poster [...]
Arbutus Announces Departure of Chief Financial Officer; Appoints Interim CFO
14/02/2018
VANCOUVER, British Columbia and WARMINSTER, Pa., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced [...]
Cannabis Wheaton Income Corp. Announces Prior Engagement of Investor Relations Firms
14/02/2018
VANCOUVER, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (the " Company ") announces that it previously retained each of IRTH Communications, LLC (" IRTH "), Skanderbeg [...]
National Research Corporation Announces Fourth Quarter and Year-End 2017 Results
14/02/2018
LINCOLN, Neb., Feb. 13, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRCIA ) (NASDAQ: NRCIB ) today announced results for the fourth quarter and year end 2017. Fourth Quarter Net New Sales $6.2 [...]
Vigil Reports Record Sales Bookings in Third Quarter
13/02/2018
VICTORIA, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (TSX-VEN: VGL) (“Vigil”) announces the results of operations for the quarter ending December 31, 2017. Business Highlights Sales [...]
Oncobiologics Receives Positive Nasdaq Listing Determination
13/02/2018
CRANBURY, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ: ONS ) (NASDAQ: ONSIW ) (NASDAQ: ONSIZ ) announced today that on February 13, 2018, the Company received formal notice that the Nasdaq [...]
Retrophin to Report Fourth Quarter and Full Year 2017 Financial Results
13/02/2018
SAN DIEGO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced it will report fourth quarter and full year 2017 financial results on Tuesday, February 27, 2018 after the close of the U.S. [...]
Avadel Pharmaceuticals Announces Proposed Exchangeable Senior Notes Offering
13/02/2018
DUBLIN, Ireland, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL ) (“Avadel” or “the Company”) today announced that its wholly-owned subsidiary, Avadel Finance Cayman Limited (the “Issuer”), [...]
Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on February 27
13/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (NASDAQ: FPRX ), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology [...]
GenMark Diagnostics Schedules Fourth Quarter and Full Year 2017 Financial Results Conference Call for February 27, 2018
13/02/2018
CARLSBAD, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK ) today announced that it plans to release its fourth quarter earnings results after market close on Tuesday, February 27, 2018 [...]
Adamas to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on February 22, 2018
13/02/2018
EMERYVILLE, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the company will report fourth quarter and full year 2017 financial results on Thursday, February [...]
Invuity Announces Fourth Quarter and Full Year 2017 Financial Results
13/02/2018
SAN FRANCISCO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announces financial results for the three months and year [...]
Amicus Therapeutics to Present at LEERINK Partners 7th Annual Global Healthcare Conference
13/02/2018
CRANBURY, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced that John F. Crowley, Chairman and Chief Executive Officer, will present a corporate overview and fireside chat at [...]
Tetraphase Announces Top-Line Results from IGNITE3 Phase 3 Clinical Trial of Eravacycline in Complicated Urinary Tract Infections (cUTI)
13/02/2018
̶ Eravacycline Did Not Achieve Co-Primary Endpoints in cUTI Trial ̶ ̶ Company Continues to Prepare for Commercialization of Eravacycline as a Treatment for cIAI in the U.S. and Europe, Assuming Regulatory Approval ̶ ̶ [...]
Incysus Presents Positive Data on Drug-Resistant Immunotherapy for Glioblastoma at AACR CNS Immunotherapy Conference
13/02/2018
NEW YORK, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, announced that Lawrence Lamb [...]
Envigo appoints Lynn Lewis as Senior Vice President of Global Sales
13/02/2018
EAST MILLSTONE, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Envigo, a leading provider of nonclinical contract research services and research models, today announced the appointment of Lynn Lewis to the position of Senior [...]

Pages